1-11 of 11
antiviral agents
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Carolyn Lutzko, Tom Leemhuis, Jose A. Cancelas, Sonata Jodele, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael S. Grimley, Adam S. Nelson
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3252–3257.
https://doi.org/10.1182/bloodadvances.2020002252
Published: 2020
Journal Articles

Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease

Laetitia Boucault, Maria-Dolores Lopez Robles, Allan Thiolat, Séverine Bézie, Michael Schmueck-Henneresse, Cécile Braudeau, Nadège Vimond, Antoine Freuchet, Elodie Autrusseau, Frédéric Charlotte, Rabah Redjoul, Florence Beckerich, Mathieu Leclerc, Eliane Piaggio, Regis Josien, Hans-Dieter Volk, Sébastien Maury, José L. Cohen, Ignacio Anegon, Carole Guillonneau
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2501–2515.
https://doi.org/10.1182/bloodadvances.2020001688
Published: 2020
Includes: Supplemental data
Journal Articles

Promoting platelets is a therapeutic option to combat severe viral infection of the lung

Jiahuang Qiu, Juan Ma, Shuping Zhang, Jinxiang Han, Sijin Liu
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1640–1642.
https://doi.org/10.1182/bloodadvances.2020001669
Published: 2020
Journal Articles

Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura
Journal: Blood Advances
Blood Adv (2020) 4 (4): 667–671.
https://doi.org/10.1182/bloodadvances.2019000343
Published: 2020
Includes: Supplemental data
Journal Articles

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy

Joshua A. Hill, Elizabeth M. Krantz, Kevin A. Hay, Sayan Dasgupta, Terry Stevens-Ayers, Rachel A. Bender Ignacio, Merav Bar, Joyce Maalouf, Sindhu Cherian, Xueyan Chen, Greg Pepper, Stanley R. Riddell, David G. Maloney, Michael J. Boeckh, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3590–3601.
https://doi.org/10.1182/bloodadvances.2019000717
Published: 2019
Includes: Supplemental data
Journal Articles

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients

Clinical Trials & Observations
Ifigeneia Tzannou, Ayumi Watanabe, Swati Naik, Rachel Daum, Manik Kuvalekar, Kathryn S. Leung, Caridad Martinez, Ghadir Sasa, Mengfen Wu, Adrian P. Gee, Robert A. Krance, Stephen Gottschalk, Helen E. Heslop, Bilal Omer
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2571–2580.
https://doi.org/10.1182/bloodadvances.2019000371
Published: 2019
Includes: Supplemental data
Journal Articles

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Clinical Trials & Observations
Allistair A. Abraham, Tami D. John, Michael D. Keller, C. Russell Y. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi J. Grilley, Adrian P. Gee, Hema Dave, David A. Jacobsohn, Robert A. Krance, Elizabeth. J. Shpall, Caridad A. Martinez, Patrick J. Hanley, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2057–2068.
https://doi.org/10.1182/bloodadvances.2019000201
Published: 2019
Includes: Supplemental data
Journal Articles

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Kaiwen Chen, Matthew P. Cheng, Sarah P. Hammond, Hermann Einsele, Francisco M. Marty
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2159–2175.
https://doi.org/10.1182/bloodadvances.2018016493
Published: 2018
Includes: Supplemental data
Journal Articles

Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Coco de Koning, Rick Admiraal, Stefan Nierkens, Jaap Jan Boelens
Journal: Blood Advances
Blood Adv (2018) 2 (4): 428–432.
https://doi.org/10.1182/bloodadvances.2017012724
Published: 2018
Journal Articles

Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs

Joseph R. Francica, Daniel E. Zak, Caitlyn Linde, Emilio Siena, Carrie Johnson, Michal Juraska, Nicole L. Yates, Bronwyn Gunn, Ennio De Gregorio, Barbara J. Flynn, Nicholas M. Valiante, Padma Malyala, Susan W. Barnett, Pampi Sarkar, Manmohan Singh, Siddhartha Jain, Margaret Ackerman, Munir Alam, Guido Ferrari, Andres Salazar, Georgia D. Tomaras, Derek T. O’Hagan, Alan Aderem, Galit Alter, Robert A. Seder
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2329–2342.
https://doi.org/10.1182/bloodadvances.2017011411
Published: 2017
Includes: Supplemental data
Journal Articles

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Clinical Trials & Observations
Barbara Withers, Emily Blyth, Leighton E. Clancy, Agnes Yong, Chris Fraser, Jane Burgess, Renee Simms, Rebecca Brown, David Kliman, Ming-Celine Dubosq, David Bishop, Gaurav Sutrave, Chun Kei Kris Ma, Peter J. Shaw, Kenneth P. Micklethwaite, David J. Gottlieb
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2193–2205.
https://doi.org/10.1182/bloodadvances.2017010223
Published: 2017
Includes: Supplemental data